MetaCap

Prime Medicine (PRME) News

NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.55-0.29 (-7.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PRME news summary

We found 8 recent headlines mentioning Prime Medicine (PRME): 0 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Seeking Alpha, Nasdaq. PRME is making an outsized move today, down 7.55% at $3.55, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Prime Medicine GAAP EPS of -$0.22 beats by $0.02, revenue of $4.21M beats by $3.13M", was published by Seeking Alpha on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Prime Medicine headlines

Stocks mentioned alongside PRME

Compare PRME